100% Overall Survival and 100% Event Free Survival in Patients Treated with OTL-101 Compared to 88% OS and 56% EvFS with Historical HSCT Overall at 24 months
The Global Digital Health 100 is one of the HealthTech industries foremost technology award programmes, celebrating innovation and entrepreneurship.
AVORA has already built an impressive client base, including Telefonica, OMD, NPR, HBO LatAm and Ocado. The UK start-up will use the funds raised to expand its leadership and sales teams, launch in the US market and continue to evolve its technology by enhancing its in-platform machine learning algorithms.
Spinout marks the first of UCLTF’s early stage investments to file for IPO.
Egress will use this investment to build on its ongoing rapid growth in Europe and North America, as well as accelerate development of new technology across its data security platform.
The funding will be used to develop Raremark’s patient-engagement and data-analysis technology.
Hazy is an AI spin-out from UCL and is one of the businesses invested in by the UCL Technology Fund which is managed by Albion in collaboration with UCLB.